Comparative studies of macrophage-biased responses in mice to infection with Toxoplasma gondii ToxoDB #9 strains of different virulence isolated from China

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Zhang, Ai Mei ^a   Shen, Qian ^a   Li, Min ^a   Xu, Xiu Cai ^a   Chen, He ^a   Cai, Yi Hong ^a   Luo, Qing Li ^a   Chu, De Yong ^a   Yu, Li ^a   Du, Jian ^a   Lun, Zhao Rong ^b   Wang, Yong ^c   Sha, Quan ^a   Shen, Ji Long ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genotyping; Macrophage activation; Macrophages; Signaling pathway; Toxoplasma gondii

Indexed keywords

ARGINASE; ARGININE; B7 ANTIGEN; CD86 ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NITRIC OXIDE; STAT3 PROTEIN; STAT6 PROTEIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PERITONEUM MACROPHAGE; PHENOTYPE; PHOSPHORYLATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION; WESTERN BLOTTING;

MUS; TOXOPLASMA GONDII;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHINA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOPHENOTYPING; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VIRULENCE;

EID: 84886154009     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-308     Document Type: Article

References (38)

1. Toxoplasma gondii: transmission, diagnosis and prevention. Hill D, Dubey JP, Clin Microbiol Infect 2002 8 634 640 10.1046/j.1469-0691.2002.00485.x 12390281 (Pubitemid 35277118)
2. Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. di Carlo P, Romano A, Casuccio A, Cillino S, Schimmenti MG, Mancuso G, la Chiusa S, Novara V, Ingrassia D, Li Vecchi V, Trizzino M, Titone L, Acta Pharmacol Sin 2011 32 1063 1070 10.1038/aps.2011.55 21743484
3. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, Cornel L, Boedec E, Ong YC, Chien YH, Hunter CA, Boothroyd JC, Saeij JP, Cell Host Microbe 2011 9 472 483 10.1016/j.chom.2011.04.015 21669396
4. Exploring the full spectrum of macrophage activation. Mosser DM, Edwards JP, Nat Rev Immunol 2008 8 958 969 10.1038/nri2448 19029990
5. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. Stein M, Keshav S, Harris N, Gordon S, J Exp Med 1992 176 287 292 10.1084/jem.176.1.287 1613462
6. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, Saeij JP, J Exp Med 2011 208 195 212 10.1084/jem.20100717 21199955
7. Just one cross appears capable of dramatically altering the population biology of a eukaryotic pathogen like Toxoplasma gondii. Boyle JP, Rajasekar B, Saeij JP, Ajioka JW, Berriman M, Paulsen I, Roos DS, Sibley LD, White MW, Boothroyd JC, Proc Natl Acad Sci U S A 2006 103 10514 10519 10.1073/pnas. 0510319103 16801557 (Pubitemid 44051198)
8. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Sibley LD, Ajioka JW, Annu Rev Microbiol 2008 62 329 351 10.1146/annurev.micro.62.081307.162925 18544039
9. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC, Science 2006 314 1780 1783 10.1126/science.1133690 17170306 (Pubitemid 44969090)
10. Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, Sibley LD, Int J Parasitol 2011 41 645 655 10.1016/j.ijpara.2011.01.005 21320505
11. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mouse-virulence of strains from Gabon. Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Banuls AL, Durand P, Salle B, Ajzenberg D, Darde ML, PLoS Negl Trop Dis 2010 4 876 10.1371/journal.pntd.0000876 21072237
12. Genotyping of Toxoplasma gondii isolates from cats in different geographic regions of China. Chen ZW, Gao JM, Huo XX, Wang L, Yu L, Halm-Lai F, Xu YH, Song WJ, Hide G, Shen JL, Lun ZR, Vet Parasitol 2011 183 166 170 10.1016/j.vetpar.2011.06.013 21757292
13. Genetic characterization of Toxoplasma gondii from pigs from different localities in China by PCR-RFLP. Jiang HH, Huang SY, Zhou DH, Zhang XX, Su C, Deng SZ, Zhu XQ, Parasit Vectors 2013 6 227 10.1186/1756-3305-6-227 23919620
14. Toxoplasma gondii prevalence in food animals and rodents in different regions of China: isolation, genotyping and mouse pathogenicity. Lin W, Hua-Wei C, Kai-Quan H, Yuan-Hong X, Yong-Nian L, Jian D, Li Y, Qing-Li L, Wei W, Ling J, Ji-Long S, Parasit Vectors 2013 6 273 10.1186/1756-3305-6-273
15. Genetic diversity among Toxoplasma gondii strains from different hosts and geographical regions revealed by sequence analysis of GRA5 gene. Chen J, Li ZY, Zhou DH, Liu GH, Zhu XQ, Parasit Vectors 2012 5 279 10.1186/1756-3305-5-279 23206419
16. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Boothroyd JC, Grigg ME, Curr Opin Microbiol 2002 5 438 442 10.1016/S1369-5274(02)00349-1 12160866
17. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Luder CG, Algner M, Lang C, Bleicher N, Gross U, Int J Parasitol 2003 33 833 844 10.1016/S0020-7519(03)00092-4 12865083 (Pubitemid 36831007)
18. Determination of arginase activity in macrophages: a micromethod. Corraliza IM, Campo ML, Soler G, Modolell M, J Immunol Methods 1994 174 231 235 10.1016/0022-1759(94)90027-2 8083527 (Pubitemid 24297154)
19. Monocytes/macrophages infected with Toxoplasma gondii do not increase co-stimulatory molecules while maintaining their migratory ability. Seipel D, Ribeiro-Gomes FL, Barcelos MW, Ramalho AV, Kanashiro MM, Kipnis TL, Arnholdt AC, APMIS 2009 117 672 680 10.1111/j.1600-0463.2009.02519.x 19703127
20. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Lang C, Algner M, Beinert N, Gross U, Luder CG, Microbes Infect 2006 8 1994 2005 10.1016/j.micinf.2006.02.031 16824778 (Pubitemid 44311590)
21. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Luder CG, Lang T, Beuerle B, Gross U, Clin Exp Immunol 1998 112 308 316 10.1046/j.1365-2249.1998.00594.x 9649196 (Pubitemid 28266692)
22. Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China. Wang L, Chen H, Liu D, Huo X, Gao J, Song X, Xu X, Huang K, Liu W, Wang Y, Lu F, Lun ZR, Luo Q, Wang X, Shen J, PLoS One 2013 8 53483 10.1371/journal.pone.0053483 23308233
23. Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction. Morgado P, Ong YC, Boothroyd JC, Lodoen MB, Infect Immun 2011 79 4401 4412 10.1128/IAI.05562-11 21911468
24. Macrophages as a battleground for Toxoplasma pathogenesis. Murray PJ, Cell Host Microbe 2011 9 445 447 10.1016/j.chom.2011.05.010 21669391
25. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, Konig T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ, Nat Immunol 2008 9 1399 1406 10.1038/ni.1671 18978793
26. Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infection. Li Z, Zhao ZJ, Zhu XQ, Ren QS, Nie FF, Gao JM, Gao XJ, Yang TB, Zhou WL, Shen JL, Wang Y, Lu FL, Chen XG, Hide G, Ayala FJ, Lun ZR, PLoS One 2012 7 35834 10.1371/journal.pone.0035834 22558235
27. Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype. Robben PM, Mordue DG, Truscott SM, Takeda K, Akira S, Sibley LD, J Immunol 2004 172 3686 3694 15004172 (Pubitemid 38337952)
28. The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Henrik L, Vutova PP, Adams WC, Karin L, Antonio B, Infect Immun 2009 77 1679 1688 10.1128/IAI.01289-08 19204091
29. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD, J Immunol 2001 167 4574 4584 11591786 (Pubitemid 32954337)
30. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY, J Immunol 2005 174 3148 3152 15749841 (Pubitemid 40354013)
31. Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Peixoto L, Chen F, Harb OS, Davis PH, Beiting DP, Brownback CS, Ouloguem D, Roos DS, Cell Host Microbe 2010 8 208 218 10.1016/j.chom.2010.07.004 20709297
32. A critical role for SOCS3 in innate resistance to Toxoplasma gondii. Whitmarsh RJ, Gray CM, Gregg B, Christian DA, May MJ, Murray PJ, Hunter CA, Cell Host Microbe 2011 10 224 236 10.1016/j.chom.2011.07.009 21925110
33. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, Yarovinsky F, Herbert DR, Bzik DJ, Denkers EY, PLoS Pathog 2011 7 1002236 10.1371/journal.ppat.1002236 21931552
34. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. Yamamoto M, Standley DM, Takashima S, Saiga H, Okuyama M, Kayama H, Kubo E, Ito H, Takaura M, Matsuda T, Soldati-Favre D, Takeda K, J Exp Med 2009 206 2747 2760 10.1084/jem.20091703 19901082
35. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis. Mordue DG, Sibley LD, J Leukoc Biol 2003 74 1015 1025 10.1189/jlb.0403164 12972511 (Pubitemid 38040323)
36. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Trinchieri G, Nat Rev Immunol 2003 3 133 146 10.1038/nri1001 12563297 (Pubitemid 37328691)
37. Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. Ong YC, Reese ML, Boothroyd JC, J Biol Chem 2010 285 28731 28740 10.1074/jbc.M110.112359 20624917
38. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC, Nature 2007 445 324 327 10.1038/nature05395 17183270 (Pubitemid 46122820)